Influenza and pertussis vaccine coverage in pregnancy in Australia, 2016-2021

Jocelynne E McRae1,2, Lisa McHugh3, Catherine King1,2

  • 1National Centre for Immunisation Research and Surveillance, Sydney, NSW.

Insights

Maternal vaccination against influenza and pertussis in Australia shows suboptimal coverage, particularly for influenza. Improving data collection is crucial for enhancing vaccination rates among at-risk pregnant women.

Area of Science:

  • Public Health
  • Immunisation
  • Maternal Health

Background:

  • Vaccination during pregnancy is vital for protecting infants from influenza and pertussis.
  • Pregnant women face increased risks from influenza, preventable by antenatal vaccination.
  • Australian National Immunisation Program funds maternal influenza and pertussis vaccines, but national coverage data is lacking.

Purpose of the Study:

  • To review Australian maternal influenza and pertussis vaccine coverage data from 2016-2021.
  • To identify gaps and information needs in current antenatal vaccination reporting.

Main Methods:

  • Systematic review of reported Australian maternal influenza and pertussis vaccine coverage data (2016-2021).
  • Analysis of jurisdictional perinatal data collections as a source of coverage information.

Main Results:

  • Maternal influenza vaccine coverage was below 58% (2016-2018), improving to 62-75% in Victoria and Western Australia (2019-2021).
  • Maternal pertussis vaccine coverage exceeded 70% (from 2016), with Western Australia reporting 89% in 2020.
  • Suboptimal coverage observed in First Nations, culturally and linguistically diverse, and lower socio-economic status pregnant women.

Conclusions:

  • Current antenatal vaccine coverage data in Australia is insufficient and lacks national consistency.
  • Improved, timely data collection is essential for targeted interventions to boost maternal vaccination rates.
  • Focus is needed on high-risk and low-uptake populations, and emerging vaccine recommendations like COVID-19.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
44.9K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.3K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
355
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
650
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.8K